Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5. | EMBO Mol Med | 2019 | 30940675 | PubTator, text mining | PubMed |
| Promyelocytic leukemia protein (PML) controls breast cancer cell proliferation by modulating Forkhead transcription factors. | Mol Oncol | 2019 | 30927552 | PubTator, text mining | PubMed |
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis. | mSphere | 2019 | 30918060 | PubTator, text mining | PubMed |
| Transcriptional Analysis of the Human IgE-Expressing Plasma Cell Differentiation Pathway. | Front Immunol | 2019 | 30915071 | PubTator, text mining | PubMed |
| The Specific Inhibition of SOD1 Selectively Promotes Apoptosis of Cancer Cells via Regulation of the ROS Signaling Network. | Oxid Med Cell Longev | 2019 | 30911355 | PubTator, text mining | PubMed |
| Boolean model of growth signaling, cell cycle and apoptosis predicts the molecular mechanism of aberrant cell cycle progression driven by hyperactive PI3K. | PLoS Comput Biol | 2019 | 30875364 | PubTator, text mining | PubMed |
| The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression. | Cell Biosci | 2019 | 30867900 | PubTator, text mining | PubMed |
| Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development. | Front Immunol | 2019 | 30842770 | PubTator, text mining | PubMed |
| Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells. | Cancer Cell Int | 2019 | 30820189 | PubTator, text mining | PubMed |
| Sex Differences in the Effects of Prenatal Bisphenol A Exposure on Genes Associated with Autism Spectrum Disorder in the Hippocampus. | Sci Rep | 2019 | 30816183 | PubTator, text mining | PubMed |
| EPAC mediates the dual role of cAMP signaling in melanoma. | Oncoscience | 2019 | 30800712 | PubTator, text mining | PubMed |
| LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer. | Oncotarget | 2019 | 30800215 | PubTator, text mining | PubMed |
| Protein Phosphatases-A Touchy Enemy in the Battle Against Glioblastomas: A Review. | Cancers (Basel) | 2019 | 30791455 | PubTator, text mining | PubMed |
| Chrysophanol: A Natural Anthraquinone with Multifaceted Biotherapeutic Potential. | Biomolecules | 2019 | 30781696 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis of Hub Genes and Pathways in Anaplastic Thyroid Carcinomas. | Int J Endocrinol | 2019 | 30774662 | PubTator, text mining | PubMed |
| Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma. | Biosci Rep | 2019 | 30765611 | PubTator, text mining | PubMed |
| Impact of HVT Vaccination on Splenic miRNA Expression in Marek's Disease Virus Infections. | Genes (Basel) | 2019 | 30764490 | PubTator, text mining | PubMed |
| Complex harmonic regularization with differential evolution in a memetic framework for biomarker selection. | PLoS One | 2019 | 30763332 | PubTator, text mining | PubMed |
| Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck. | Clin Cancer Res | 2019 | 30755439 | PubTator, text mining | PubMed |
| C/EBPβ Is a Transcriptional Regulator of Wee1 at the G₂/M Phase of the Cell Cycle. | Cells | 2019 | 30754676 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=41